HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA developing proposal to allow for greater public input, FDA's Shultz says.

This article was originally published in The Rose Sheet

Executive Summary

FDA GUIDANCE DEVELOPMENT WILL PROVIDE FOR PUBLIC COMMENT under an agency policy on informal rulemaking procedures to be released in October, FDA Deputy Commissioner for Policy William Schultz announced Sept. 14 at a House Government Reform Committee hearing. The hearing was held jointly by Rep. Christopher Shays' (R-CT) Human Resources Subcommittee and Rep. David McIntosh's (R-IN) National Economic Growth Subcommittee.
UsernamePublicRestriction

Register

RS002042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel